A strong and controversial drug is suddenly back in the spotlight. It is called ibogaine. People are talking about it not just for health reasons, but also because of politics. The discussion picked up after podcaster Joe Rogan spoke about it and shared details with Donald Trump. Ibogaine is not new. It comes from a plant found in West Africa. For years, it has been used in traditional ceremonies. Now, it is being looked at as a possible treatment for serious mental health issues like PTSD and addiction. At the same time, it comes with real dangers. That is why the topic is now getting both support and criticism.
Joe Rogan and Donald Trump connection brings ibogaine into national spotlight
The link between ibogaine, Joe Rogan, and Donald Trump started with a simple message. Rogan shared information about the drug and how it may help veterans dealing with trauma and addiction. According to Rogan, Trump replied quickly and showed interest.Trump later spoke about it publicly. During a White House event, he even joked, “Can I have some, please? I’ll take some. I don’t have time to be depressed.”Soon after, Trump signed an order to speed up research on such treatments. The goal is to make studies faster and help people who are struggling with serious conditions. Reports say the plan includes funding and faster review timelines from the FDA.The topic also got support from people across politics. Health Secretary Robert F. Kennedy Jr. backed the move. Former Navy SEAL Marcus Luttrell shared his personal experience and said, “It absolutely changed my life.”But the story doesn’t end there. Ibogaine is still a banned substance in the United States. It is listed as a Schedule I drug, which means it is not approved for medical use. One reason is safety. Studies, including work referenced by Stanford Universityshowed improvement in some patients. But health experts warn about serious risks.Researchers from Johns Hopkins University, including Frederick Barrett, explained the concern clearly. He said, “It’s been incredibly difficult to study ibogaine in the US because of its known cardiotoxicity.”This means the drug can affect the heart. There have been reports of dangerous heart rhythms and even deaths linked to it. Because of this, many patients travel to clinics in Mexico, where treatments are monitored closely.So right now, ibogaine sits in a strange place. It offers hope to some people, especially veterans. But it also carries risks that cannot be ignored. That is why this conversation is growing so fast across health and political spaces.
